Research Daily Summary
Research Daily Summary: What Happened on November 19, 2026
UCLA researchers restore gene activity in autism models
Other teams used AI to design functional RNA and identify genomic features resembling CRISPR.
Today in brief
UCLA researchers used CRISPR activation to boost two autism-risk genes in neuronal cells and brain organoids.1 In separate studies, researchers used AI to design functional RNA, and Anthropic scientists said AI agents found genomic features resembling CRISPR.23
CRISPR activation restored gene activity in autism models
UCLA researchers used enhancer-targeted CRISPR activation to boost CHD8 and SCN2A expression in neuronal cells and brain organoids.1 In CHD8 models, the intervention brought activity closer to typical levels, supported normal cell maturation and reduced abnormal organoid growth.1
In SCN2A models, it largely restored normal neuronal electrical activity, although some details remained impaired in certain cell lines.1 Expression rose in mutant models but not in healthy cells. Researchers intervened 25 days into CHD8 organoid development and 100 days into SCN2A development.1
The findings come from cell and organoid models, not clinical testing.1 Study first author George Chen said delivery and timing require substantial further study before the approach could be used clinically.1
Also worth knowing
-
RhoAgent, an AI system for designing and refining functional RNA, produced active ribozymes with 40–70% sequence similarity to their natural counterparts. It improved one ribozyme’s cleavage efficiency by up to sixfold versus a construct shortened by human experts, and produced an aptamer scaffold with 230% greater fluorescence than the natural version.2
-
O
Anthropic scientists said AI agents found repeat arrays beside specific proteins in genomic regions resembling CRISPR. One protein was predicted to be a reverse transcriptase, while the other’s function remained unclear.3